Profound Medical Corp

NASDAQ:PROF  
7.72
-0.18 (-2.28%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)189.00M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.05 Million
Adjusted EPS-$0.30
See more estimates
10-Day MA$8.19
50-Day MA$9.35
200-Day MA$8.66
See more pivots

Profound Medical Corp Stock, NASDAQ:PROF

2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5
Canada
Phone: +1.647.476.1350
Number of Employees: 131
http://www.profoundmedical.com

Description

Profound Medical Corp. engages in developing, manufacturing, and marketing of therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care, which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, Canada.